UNSPSC 51284122: Cefodizime

This classification denotes a beta-lactam antibacterial with the molecular formula C20H20N6O7S4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HC1T51593A, chemically known as (6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(((5-(carboxymethyl)-4-methyl-2-thiazolyl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(z)-(o-methyloxime) but generally known as cefodizime, which bears US NIH Compound Identifier 5361871. Most nations schedule cefodizime under HS 29419000 and SITC 54139.

As of Q4 2014, CEFODIZIME remains the US FDA Preferred Term for this commodity. Cefodizime bears US NLM identifiers UMLS ID C0055007 and NCI Concept Code C98224. SMILES: CC1=C(SC(=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O)CC(=O)O.

UNSPSC 51284122 Cefodizime, a Commodity code, does not align with the state and local contract opportunities recently tagged under it. The code nominally describes a specific third-generation cephalosporin antibiotic, but the recent solicitations posted under this code instead cover naloxone and drug deactivation systems, broad medical and first aid supplies for fire rescue, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer pharmacy benefit programs. State and local governments do not appear to be actively procuring cefodizime as a discrete pharmaceutical product at present; the code's recent activity reflects either misclassification by issuing bodies or a mismatch between UNSPSC taxonomy and actual purchasing patterns in this category.

Across the four recent opportunities, issuing bodies include a county health department (Seminole County, Florida), a state health and human services agency (Texas HHS Commission), a municipal fire department (City of Tampa), and a multistate cooperative purchasing alliance (Minnesota MMCAP, serving Minnesota and Oregon). The geographic spread is limited — Florida, Texas, and the upper Midwest. Seminole County issued an IFB for naloxone and drug deactivation systems (1,900 units of naloxone and 800 deactivation systems annually) with a response deadline of July 26, 2023. The City of Tampa issued a bid for medical and first aid supplies covering 169 line items of emergency response consumables due March 13, 2026, with an estimated contract value of $700,000, designated as a sheltered-market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. Minnesota MMCAP issued an RFP for generic multi-source pharmaceuticals and OTC products with a proposal deadline of March 26, 2026. The Texas HHS Commission posted an RFI regarding direct-to-manufacturer pharmacy benefit programs with a response deadline of April 3, 2026.